Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.8	71.64	86.89	38.25	84.7	19.84
Cash & Short-Term Investments	48.8	71.64	86.89	38.25	84.7	19.84
Cash Growth	-58.81%	-17.55%	127.16%	-54.84%	326.96%	-26.97%
Other Receivables	-	-	0.25	0.91	0.55	0.6
Receivables	-	-	0.25	0.91	0.55	0.6
Prepaid Expenses	1.82	1.57	1.19	1.61	2.29	0.04
Other Current Assets	2.56	2.6	0.62	0.96	0.29	0.2
Total Current Assets	53.17	75.81	88.94	41.73	87.83	20.69
Property, Plant & Equipment	3.47	2.85	4.19	5.45	4.83	2.03
Other Long-Term Assets	0.95	1.24	1.76	1.18	0.99	0.64
Total Assets	57.6	79.9	94.89	48.36	93.65	23.36
Accounts Payable	3	4.03	4.15	1.77	3.92	1.42
Accrued Expenses	6.73	9.52	6.94	4.24	2.81	2.05
Current Portion of Leases	1.84	1.09	0.97	0.87	0.51	-
Other Current Liabilities	0.77	0.6	0.32	0.19	0.79	0.55
Total Current Liabilities	12.33	15.24	12.37	7.07	8.02	4.01
Long-Term Leases	0.76	0.72	1.81	2.79	2.38	1.62
Long-Term Unearned Revenue	2.26	2.26	2.26	2.26	0.6	0.6
Other Long-Term Liabilities	-	-	-	0.26	13.14	8.41
Total Liabilities	15.35	18.23	16.45	12.37	24.14	14.65
Common Stock	0	0	0	-	0	0
Additional Paid-In Capital	304.35	302.54	248.04	141.12	136.96	1.68
Retained Earnings	-262.11	-240.87	-169.6	-105.14	-67.45	-36.81
Total Common Equity	42.24	61.67	78.44	35.99	69.52	-35.13
Shareholders' Equity	42.24	61.67	78.44	35.99	69.52	8.71
Total Liabilities & Equity	57.6	79.9	94.89	48.36	93.65	23.36
Total Debt	2.59	1.81	2.79	3.65	2.89	1.62
Net Cash (Debt)	46.21	69.82	84.1	34.6	81.82	18.21
Net Cash Growth	-60.14%	-16.98%	143.07%	-57.71%	349.19%	-32.95%
Net Cash Per Share	3.08	4.79	8.06	9.48	71.81	105.29
Filing Date Shares Outstanding	15.02	15.02	15.06	10.94	4.95	10.16
Total Common Shares Outstanding	15.02	15.02	11.16	4.62	4.95	9.81
Working Capital	40.84	60.57	76.56	34.67	79.81	16.67
Book Value Per Share	2.81	4.11	7.03	7.78	14.04	-3.58
Tangible Book Value	42.24	61.67	78.44	35.99	69.52	-35.13
Tangible Book Value Per Share	2.81	4.11	7.03	7.78	14.04	-3.58
Machinery	2.88	2.88	2.62	2.35	1.92	0.44
Leasehold Improvements	2.71	2.71	2.48	2.48	2.06	0.26

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q